LRP-5

LRP-5

LRP-5 Overview

Molecule Name
Low-density lipoprotein receptor-related protein 5
Drug Development Progress
Drugs in Clinical Trials2
Approved Drugs0
Highest Development StagePhase 3 Clinical
Target Synonym
Background
Low-density lipoprotein receptor-related protein 5(LRP-5) is also known as BMND1, EVR1, EVR4, HBM, LR3, LRP7, OPPG, OPTA1, VBCH2, LDL receptor related protein 5 and PCLD4. LRP5 is a transmembrane low-density lipoprotein receptor that shares a similar structure with LRP6. LRP5 acts as a co-receptor with LRP6 and the Frizzled protein family members for transducing signals by Wnt proteins through the canonical Wnt pathway. This protein plays a key role in skeletal homeostasis. Mutations in LRP5 can lead to considerable changes in bone mass. A loss-of-function mutation causes osteoporosis-pseudoglioma (decrease in bone mass), while a gain-of-function mutation causes drastic increases in bone mass.

LRP-5 Product List

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
RestoretEYE103; EYE-103; MK-3000; ANT-39Phase 3 ClinicalEyebiotech Ltd
Diabetic macular oedema; Macular Degeneration; Retinal Vein Occlusion
Details
BI-905681BI-905681Phase 1 ClinicalBoehringer Ingelheim Ltd
Neoplasms
Details